Several studies evaluated visfatin levels in NAFLD, the presence and severity of hepatic steatosis, liver fibrosis, lobar inflammation, nonalcoholic steatohepatitis (NASH), and gender differences. The gene discussed is NAMPT; the disease is metabolic dysfunction-associated steatohepatitis.